6 结果
CROSS-REFERENCE TO RELATED APPLICATIONS
This application is the National Stage of International Application No. PCT/EP2004/005362, filed May 18, 2004.
The present invention relates to novel nutraceutical compositions comprising, as the active ingredients, resveratrol, a derivative, metabolite or
This application is the U.S. national phase of International Application No. PCT/EP2007/006188, filed 12 Jul. 2007, which designated the U.S. and claims priority to European Application No. 06014645.3, filed 14 Jul. 2006, the entire contents of each of which are hereby incorporated by reference.
The
INTRODUCTION
Adequate sleep promotes health and the immune system. Sleep disorders and complaints can occur during childhood, adolescence or adult life [1, 2]. Insufficient sleep affects children's physical health as well as emotional, cognitive and social development. In the youth and adolescent
INTRODUCTION
Adequate sleep promotes health and the immune system. Sleep disorders and complaints can occur during childhood, adolescence or adult life [1, 2]. Insufficient sleep affects children's physical health as well as emotional, cognitive and social development. In the youth and adolescent
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to topical compositions for reducing, preventing, or reversing damage to the eyes resulting from oxidative stress (dry eye, cataracts, retinal degeneration, etc.), and particularly to antioxidant eye drops containing
BACKGROUND OF THE INVENTION
Oral inflammations, such as gingivitis and periodontitis, are common oral conditions. Gingivitis, which is an inflammation of the gums, is the initial stage of gum disease. The direct cause of gingivitis is plaque, which is a soft, sticky, colorless film including